# Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery

> **NCT07643792** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 148 (estimated)

## Conditions studied

- Fascia Iliaca Block
- Liposomal Bupivacaine
- Postoperative Pain
- Hip Surgery

## Interventions

- **DRUG:** Liposomal bupivacaine (LB)
- **DRUG:** Plain bupivacaine

## Key facts

- **NCT ID:** NCT07643792
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-06
- **Final completion:** 2028-08
- **Target enrollment:** 148 (ESTIMATED)
- **Last updated:** 2026-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643792, "Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07643792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*